Divi’s Laboratories Q2FY26 Profit Rises 35% YoY to ₹689 Crore, Revenue Up 16%; Shares Price Down 4%

Hyderabad, November 7, 2025: Divi’s Laboratories’ share price closed at ₹6,607, down 4.02% on Friday on the NSE, despite reporting a strong quarterly performance. The company posted a consolidated net profit of ₹689 crore for Q2FY26, up 35% year-on-year, driven by healthy revenue growth and operational efficiencies. Consolidated revenue from operations rose 16% YoY to ₹2,715 crore, while total income reached ₹2,860 crore, a 17% increase. The company also reported foreign exchange gains of ₹63 crore, up from ₹34 crore a year earlier.

Divi’s Laboratories Limited is a leading manufacturer of Active Pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients. The pharma company is listed on both the BSE and the NSE. It also operated state-of-the-art manufacturing facilities spanning India. Divi’s Laboratories also maintains a strong global clientele.

Standalone Performance Highlights

On a standalone basis, total income for Q2FY26 stood at ₹2,806 crore, compared to ₹2,407 crore in Q2FY25. Profit before tax increased to ₹920 crore from ₹735 crore, and profit after tax rose to ₹696 crore from ₹518 crore. For H1FY26, standalone PAT reached ₹1,253 crore, up from ₹948 crore in the corresponding period last year.

Share Price Update

On Friday, Divi’s Laboratories shares opened at ₹6,874, reached a high of ₹6,892, and touched a low of ₹6,601. The stock has gained 10.86% over the past year, 8.79% year-to-date, and 7.47% in the last six months, while declining 2.88% in the past five days.

REF: https://nsearchives.nseindia.com/corporate/DIVISLAB_07112025120530_Outcome_BoardMeeting_07112025.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations